EA
TEVA icon

Emerald Acquisition’s Teva Pharmaceuticals TEVA Stock Holding History

Emerald Acquisition’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$94.2M Sell
2,047,223
-592,190
-22% -$30.9M 0.18% 127
2016
Q2 		$133M Buy
+2,639,413
New +$141M 0.23% 91

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Emerald Acquisition's TEVA Position: Q3 2016 in Review

Emerald Acquisition reduced its Teva Pharmaceuticals (TEVA) stake by 22% in Q3 2016, selling an estimated $30.9M and leaving 2,047,223 shares worth $94.2M. The position accounts for 0.18% of the portfolio, ranked #127.

Emerald Acquisition first reported a position in TEVA in Q2 2016 and has held it in 2 quarters since. The position peaked at $133M in Q2 2016. 795 funds tracked by Wall St. Rank hold TEVA as of Q3 2016.

  • Emerald Acquisition held 2,047,223 shares of Teva Pharmaceuticals worth $94.2M as of Q3 2016.
  • Emerald Acquisition sold 592,190 Teva Pharmaceuticals shares in Q3 2016, an estimated $30.9M.
  • Teva Pharmaceuticals made up 0.18% of Emerald Acquisition's portfolio in Q3 2016, its #127 holding.
  • Emerald Acquisition first reported a position in Teva Pharmaceuticals in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Teva Pharmaceuticals position peaked at $133M in Q2 2016.
  • 795 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.